Monoclonal antibody treatment for COVID-19, Aug. 30

Getting diagnosed with COVID-19 can be scary. However, in addition to the safe and effective vaccines we have in the U.S., we now have more treatments available that can reduce the severity of COVID-19 in those who have become infected. Monoclonal antibody (mAb) treatments have the potential to save lives and relieve the burden currently placed on Oregon’s health care system. The treatment is now available in both subcutaneous (an injection) and intravenous (IV) form. One monoclonal antibody treatment is currently available in Oregon through Health and Human Services (HHS) for free and has proven to be effective against the Delta variant. People ages 12 and older, who weigh at least 88 lbs. and meet the following requirements may be eligible for mAb treatment: Have tested positive for COVID-19. Are experiencing mild or moderate symptoms of COVID-19. Had first symptoms within the last 10 days. Are considered high risk for going into the hospital because of age, weight, pregnancy, immunosuppressive disease or treatment for some other chronic disease. See the full list. To learn more about mAb treatment, read the full story on Oregon Vaccine News.